Three Indicted for Violations of the Federal Controlled Substances Act Resulting in Death
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Articles
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Emerging Drug Trends
    • Illegal Online Pharmacies
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Emerging Drug Trends
    • Illegal Online Pharmacies
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Three Indicted for Violations of the Federal Controlled Substances Act Resulting in Death

Three Indicted for Violations of the Federal Controlled Substances Act Resulting in Death

October 30, 2026
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Public Information Officer
Phone Number: 571-362-2805

NEW ORLEANS – United States Attorney David I. Courcelle announced that IVORY CARTER (“CARTER”) age 44, DONNISHA BROWN (“BROWN”) age 42, AND CHRISTOPHER LEHMANN (“LEHMANN”) age 30, were charged in a recently unsealed four-count indictment on October 1, 2026.

Count One charged CARTER, BROWN, and LEHMANN with conspiracy to distribute fentanyl resulting in death, in violation of Title 21, United States Code, Sections 841(a)(1), 841(b)(1)(C), and 846. Count Two charged LEHMANN with distribution of a controlled substance to a pregnant individual, in violation of Title 21, United States Code, Sections 861(f), 841(a)(1), 841(b)(1)(C), and Title 18, United States Code, Section 2. Count Three charged CARTER with possession with intent to distribute controlled substances, in violation of Title 21, United States Code, Section 841(a)(1) and 841(b)(1)(C). Count Four charged LEHMANN with being an accessory after the fact, in violation of Title 18, United States Code, Section 3.

According to court records, beginning on a date unknown, but at least by December 27, 2025 and continuing to on or about December 28, 2025, in the Eastern District of Louisiana, CARTER, BROWN, and LEHMANN did knowingly and intentionally conspire to distribute a quantity of fentanyl to an individual, whose serious bodily injury and death resulted from the use of the substance.

If convicted of Count One, CARTER faces a term of imprisonment of life and a fine of up to $1,000,000.00. If convicted of Count Three, CARTER faces a term of imprisonment of up to twenty years, a fine of up to $1,000,000.00, and at least three years of supervised release.

If convicted of Count One, BROWN and LEHMANN face a term of imprisonment of no less than twenty years, a fine of up to $1,000,000.00 and at least three years of supervised release. If convicted of Count Four, LEHMANN faces a term of imprisonment of up to fifteen years.

The defendants also face payment of a $100 mandatory special assessment fee per count. 

U.S. Attorney Courcelle reiterated that the indictment is merely a charging document and that the guilt of the defendant must be proven beyond a reasonable doubt.

The case was investigated by the Drug Enforcement Administration's Fentanyl Overdose Response Team (FORT) and the St. Charles Parish Sheriff’s Office.  The prosecution is being handled by Assistant United States Attorney Briana Williams of the Narcotics Unit. 

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

John P. Scott Special Agent in Charge - New Orleans
@DEANewOrleans
  • Facebook
  • X
  • linkedin
  • Email
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster